ICP
TMO icon

Ilex Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Ilex Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.2M Buy
+92,014
New +$49.9M 1.11% 35
2025
Q1 		– Sell
-109,534
Closed -$57M – 204
2024
Q4 		$57M Buy
+109,534
New +$60.2M 3.65% 9
2024
Q3 		– Sell
-145,743
Closed -$80.6M – 34
2024
Q2 		$80.6M Buy
145,743
+134,413
+1,186% +$77M 8.26% 3
2024
Q1 		$6.59M Buy
+11,330
New +$6.36M 0.65% 18

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ilex Capital Partners's TMO Position: Q1 2026 in Review

Ilex Capital Partners opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 92,014 shares worth $45.2M. The stake represents 1.11% of the portfolio and ranks #35 among its holdings. This is a return to the name: Ilex Capital Partners previously reported a position in TMO as recently as Q4 2024.

Ilex Capital Partners first reported a position in TMO in Q1 2024 and has held it in 4 quarters since. The position peaked at $80.6M in Q2 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Ilex Capital Partners held 92,014 shares of Thermo Fisher Scientific worth $45.2M as of Q1 2026.
  • Thermo Fisher Scientific was a new Ilex Capital Partners position in Q1 2026.
  • Thermo Fisher Scientific made up 1.11% of Ilex Capital Partners's portfolio in Q1 2026, its #35 holding.
  • Ilex Capital Partners first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 4 quarters since.
  • Ilex Capital Partners's Thermo Fisher Scientific position peaked at $80.6M in Q2 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Ilex Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.